Investor Relations

BioXcel Therapeutics, Inc.
Mary Coleman
VP of Investment Relations
T: 475-238-6837

Transfer Agent

American Stock Transfer and Trust

Auditor

Ernst & Young LLP

Legal Counsel

Latham & Watkins LLP